Universal CAR-T Cell Therapy for NHL
This is a single-center, single-arm, open-label clinical study, and the sample size is set to 3-6 subjects.
Trial Details
- NCT ID
- NCT07248163
- Phase
- NA
- Sponsor
- Bioray Laboratories
- Status
- RECRUITING
- Cancer Type
- Lymphoma
- Interventions
- Locations (sample)
- Shanghai, China|31.22222,121.45806
Key Eligibility Criteria
- Willing to participate in this clinical study and sign an informed consent form;
- Age ≥ 18 years old;
- Estimated survival time ≥ 3 months;
- At least one measurable lesion;
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Lymphoma Trials on Trialify →